Below are the financial statements of BeOne Medicines, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Product revenue, net | 3.78a | 2.19a | 1.25a |
| Collaboration revenue | 0.03a | 0.27a | 0.16a |
| Total revenues | 3.81a | 2.46a | 1.42a |
| Cost of sales - product | -0.59a | -0.38a | -0.29a |
| Gross profit | 3.22a | 2.08a | 1.13a |
| Operating expenses | — | — | — |
| Research and development | -1.95a | -1.78a | -1.64a |
| Selling, general and administrative | -1.83a | -1.51a | -1.28a |
| Total operating expenses | -3.78a | -3.29a | -2.92a |
| Loss from operations | -0.57a | -1.21a | -1.79a |
| Interest income, net | 0.05a | 0.07a | 0.05a |
| Other (expense) income, net | -0.01a | 0.31a | -0.22a |
| Loss before income taxes | -0.53a | -0.83a | -1.96a |
| Income tax expense | -0.11a | -0.06a | -0.04a |
| Net loss | -0.64a | -0.88a | -2a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BeOne Medicines’s data sources below and access millions more through our Disclosure Search.